Encyclia Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 1.80 M
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.02 M
- Satisfied Charges ₹ 5.00 M
- Revenue Growth -8.03%
- Profit Growth 143.58%
- Ebitda 47.38%
- Net Worth 17.44%
- Total Assets -7.42%
About Encyclia Pharmaceuticals
Encyclia Pharmaceuticals Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 November 2012 and has a history of 12 years and three months. Its registered office is in Delhi, India.
The Corporate was formerly known as Encyclia Private Limited. The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.80 M.
The company currently has active open charges totaling ₹2.02 M. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Atish Kumar and Koushlia Devi serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U80100DL2012PTC244482
- Company No.
244482
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Encyclia Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atish Kumar  | Director | 05-Nov-2012 | Current |
| Koushlia Devi | Additional Director | 18-Aug-2023 | Current |
Financial Performance of Encyclia Pharmaceuticals.
Encyclia Pharmaceuticals Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 8.03% decrease. The company also saw a substantial improvement in profitability, with a 143.58% increase in profit. The company's net worth Soared by an impressive increase of 17.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Encyclia Pharmaceuticals?
In 2019, Encyclia Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Encyclia Care Private LimitedAtish Kumar is a mutual person
- Prakriti Pai Pai Nidhi Limited
Atish Kumar and Koushlia Devi are mutual person
- Koshiv Enterprises Private Limited
Atish Kumar is a mutual person
- Miltonia Welfare Federation
Atish Kumar is a mutual person
Charges (Loans)
₹2.02 M
₹5.00 M
Charges Breakdown by Lending Institutions
- Others : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2019 | Others | ₹2.02 M | Open |
| 04 Mar 2013 | Punjab National Bank | ₹5.00 M | Satisfied |
How Many Employees Work at Encyclia Pharmaceuticals?
Unlock and access historical data on people associated with Encyclia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Encyclia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Encyclia Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
